WuXi Biologics (Cayman) Inc

Common Name

WuXi Biologics (Cayman)

Country

China (Mainland)

Sector

Healthcare

Industry

Biotechnology

Employees

12,575

Ticker

2269

Exchange

HONG KONG EXCHANGES AND CLEARING LTD

Website

www.wuxibiologics.com

Description

Wuxi Biologics (Cayman) Inc. is a major player in the biotechnology and medical research sector, specializing in providing comprehensive solutions for the discovery, development, and manufacturing of ... Show more

Financial Statements of WuXi Biologics (Cayman)

Below are the financial statements of WuXi Biologics (Cayman), including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of CNY	2024	2023
Non-current assets	—	—
Property, plant and equipment	26,070.46^a	27,377.64^a
Right-of-use assets	2,364.92^a	2,561.83^a
Goodwill	1,529.91^a	1,529.91^a
Intangible assets	442.37^a	511.83^a
Investment of an associate measured at fair value through profit or loss (FVTPL)	1,266.56^a	1,393.53^a
Equity instruments at FVTOCI	0^a	21.41^a
Financial assets at FVTPL	1,133.27^a	1,519.35^a
Finance lease receivables	85.67^a	165.5^a
Deferred tax assets	444.32^a	235.78^a
Other long-term deposits and prepayments	66.78^a	60.69^a
Current assets	—	—
Inventories	1,521.67^a	1,765.75^a
Finance lease receivables	11.03^a	21.58^a
Trade and other receivables	6,240.75^a	6,292.68^a
Contract assets	191.93^a	499.67^a
Contract costs	1,492.93^a	1,223.7^a
Tax recoverable	14.11^a	5.77^a
Derivative financial assets	0^a	127.65^a
Financial assets at FVTPL	523.59^a	1,233.6^a
Pledged bank deposits	13.85^a	18.02^a
Time deposits	1,907.02^a	340^a
Bank balances and cash	8,279.18^a	9,669.84^a
Assets classified as held for sale	3,377.14^a	0^a
Current liabilities	—	—
Trade and other payables	2,778.2^a	2,755.77^a
Borrowings	2,435.3^a	576.33^a
Contract liabilities	2,355.77^a	3,089.76^a
Income tax payable	647.66^a	618.88^a
Lease liabilities	183.7^a	154.98^a
Derivative financial liabilities	220.62^a	440.29^a
Net current assets	14,951.94^a	13,562.23^a
Total assets less current liabilities	48,356.18^a	48,939.71^a
Non-current liabilities	—	—
Deferred tax liabilities	97.31^a	122.54^a
Borrowings	200.9^a	1,571.05^a
Contract liabilities	142.77^a	711.22^a
Lease liabilities	2,119.95^a	2,259.01^a
Deferred income	317.7^a	258.02^a
Net assets	45,477.57^a	44,017.88^a
Capital and reserves	—	—
Share capital	0.23^a	0.24^a
Reserves	41,818.98^a	40,331.36^a
Equity attributable to owners of the Company	41,819.21^a	40,331.6^a
Non-controlling interests	3,658.36^a	3,686.29^a
Total equity	45,477.57^a	44,017.88^a

Verified Sources Behind WuXi Biologics (Cayman)’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore WuXi Biologics (Cayman)’s data sources below and access millions more through our Disclosure Search.

a. WuXi Biologics (Cayman)'s Annual Report 2024

Trace every data point back to WuXi Biologics (Cayman)’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

WuXi Biologics (Cayman) Inc

Financial Statements of WuXi Biologics (Cayman)

Verified Sources Behind WuXi Biologics (Cayman)’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Pharmaron Beijing Co Ltd

Zai Lab Ltd

Akeso Inc

Genscript Biotech Corp

Joincare Pharmaceutical Group Industry Co Ltd

Tasly Pharmaceutical Group Co Ltd